Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monosodium urate (MSU) crystals are the crystalline form of monosodium urate, a salt derived from uric acid. They are best known as the causative agent in gout, where their deposition in joints and tissues triggers acute inflammatory responses. MSU crystals act as endogenous danger signals (DAMPs), potently activating the innate immune system by activating the NLRP3 inflammasome, leading to the release of pro-inflammatory cytokines IL-1β and IL-18. While not a direct drug target, their formation and deposition are the focus of therapeutic intervention in gout.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monosodium Urate Crystals (MSU).